@MurphyProf giving a wonderful talk on the transformation of transfusion medicine over the last decades.
Mike has helped lead the field & delivered enormous improvements in transfusion safety & appropriate transfusion practise. An incredible career.
@OxfordHaem
“One of Mo’s greatest accomplishments was founding @tmrjournal which still thrives today.”
We welcome you to read and become inspired by the Reflections of Dr. Morris Blajchman (1940-2022) 👉🏾https://t.co/qClrvHJ6ag written by Nancy Heddle.
🩸#BlooducationLegend
@neilblumberg1@ClinChemMD@HermelinMD@RhBloodGroup @Clinpathman Also see David Weatherall's excellent review of Clarke's work.
Br J Haematol. 2012 Apr;157(1):41-6. doi: 10.1111/j.1365-2141.2012.09031.x. Epub 2012 Feb 8.
PMID: 22313284
Queen Mary University of London: Stop the rebranding Barts and The London School of Medicine and Dentistry by QMUL - Sign the Petition! https://t.co/sZ17OvcqM6 via @UKChange
Monoclonals are effective in COVID - The dose of mAbs is x1000 greater in mAb therapy than with convalescent plasma – so high abs effective if patient has no antibodies of their own
mAbs cuts deaths among patients with no Covid antibodies https://t.co/Y0T0zwrR8P
We are all facing critical shortages in the blood supply particularly in O- group pRBCs. It’s a opportune time to review the @aabb bulletin by @MurphyProf and @debrasb 👉🏼https://t.co/ptR5eZDUTB
🩸🅾️Also, its a great time to donate blood. 🙏🏼Thank you in advance.
Latest in the @bmj_latest#choosingwisely series - Reducing unnecessary red blood cell transfusion in hospitalised patients by @NishilaMehta, @MurphyProf, Lawrie Kaplan, and our Chair Dr. Levinson:
https://t.co/EH3ubfIthE
I'm both😢 and 😃! The #blooducation world will soon be missing a true friend as the wonderful #MagdaYang moves on from managing the @AABB account to a great new opportunity. Magda is a tireless champion of BB/TM education and interaction, & I'll miss her! #ThanksMagda
Well done to all those who worked so hard to provide these excellent recommendations for the future direction of transfusion services in England. Let's work even harder to implement them!
Tweet #1 of 2: Harvey Alter won the Nobel Prize today! When I was a resident, “non-A, non-B” hepatitis was a great scourge. His discovery of hepatitis C improved the safety of the blood supply, enhanced understanding of liver cancer, and led to a cure this type of hepatitis.
@LouiseSherlike1@Andrea83311045 @PBM_NHS Congratulations, Louise and Andrea. I hope it will be widely used and be helpful in educating those making transfusion decisions in our hospitals and in driving PBM. Thank you for asking me to work with you to develop it.
'In these moments of darkness, there are moments of glimmer and hope' - @adilray
Since yesterday's programme which featured a segment on donating Covid-19 blood plasma, more than 2000 people registered to donate their plasma.
🙏